Return to study ST000367 main page

Download data matrix(Distinctly perturbed metabolic networks underlie differential tumor tissue damages induced by immune modulator b-glucan in a two-case ex vivo non-small cell lung cancer study Precellys homogenization (IC-FTMS1))

Download data matrix(Distinctly perturbed metabolic networks underlie differential tumor tissue damages induced by immune modulator b-glucan in a two-case ex vivo non-small cell lung cancer study Retsch homogenization (IC-FTMS2))

AnalysisSamplesFactorsUnits
Precellys homogenization (IC-FTMS1)15_UK21Treatment:13C6Glc_100ug/ml b-glucan | Tissue type:nontumornormalized corrected peak area
Precellys homogenization (IC-FTMS1)07_UK21Treatment:13C6Glc_100ug/ml b-glucan | Tissue type:tumornormalized corrected peak area
Precellys homogenization (IC-FTMS1)13_UK21Treatment:13C6Glc | Tissue type:nontumornormalized corrected peak area
Precellys homogenization (IC-FTMS1)05_UK21Treatment:13C6Glc | Tissue type:tumornormalized corrected peak area
Retsch homogenization (IC-FTMS2)33_UK49Treatment:13C6Glc_100ug/ml b-glucan | Tissue type:nontumornormalized corrected peak area
Retsch homogenization (IC-FTMS2)34_UK49Treatment:13C6Glc_100ug/ml b-glucan | Tissue type:nontumornormalized corrected peak area
Retsch homogenization (IC-FTMS2)03_UK49Treatment:13C6Glc_100ug/ml b-glucan | Tissue type:tumornormalized corrected peak area
Retsch homogenization (IC-FTMS2)04_UK49Treatment:13C6Glc_100ug/ml b-glucan | Tissue type:tumornormalized corrected peak area
Retsch homogenization (IC-FTMS2)31_UK49Treatment:13C6Glc | Tissue type:nontumornormalized corrected peak area
Retsch homogenization (IC-FTMS2)32_UK49Treatment:13C6Glc | Tissue type:nontumornormalized corrected peak area
Retsch homogenization (IC-FTMS2)01_UK49Treatment:13C6Glc | Tissue type:tumornormalized corrected peak area
Retsch homogenization (IC-FTMS2)02_UK49Treatment:13C6Glc | Tissue type:tumornormalized corrected peak area
  logo